High-dose, intermittent sunitinib as an alternative treatment strategy

Maria Rovithi; Richard R. de Haas; Richard J. Honeywell; Johannes Voortman; Arjan W. Griffioen; Mariette Labots; Anne Marije Luik; Godefridus J. Peters; Henk J. Broxterman; Henk M. W. Verheul

doi:https://doi.org/10.1158/1538-7445.AM2014-2989

High-dose, intermittent sunitinib as an alternative treatment strategy

Maria Rovithi, Richard R. de Haas, Richard J. Honeywell, Johannes Voortman, Arjan W. Griffioen, Mariette Labots, Anne Marije Luik, Godefridus J. Peters, Henk J. Broxterman, Henk M. W. Verheul

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Cancer research
Volume	74
Issue number	19
DOIs	https://doi.org/10.1158/1538-7445.AM2014-2989 https://doi.org/10.1158/1538-7445.AM2014-2989
Publication status	Published - 1 Oct 2014

Access to Document

Cite this

@article{4908805cfc8649b7aef3a1ae7c2a16c8,

title = "High-dose, intermittent sunitinib as an alternative treatment strategy",

author = "Maria Rovithi and {de Haas}, {Richard R.} and Honeywell, {Richard J.} and Johannes Voortman and Griffioen, {Arjan W.} and Mariette Labots and Luik, {Anne Marije} and Peters, {Godefridus J.} and Broxterman, {Henk J.} and Verheul, {Henk M. W.}",

year = "2014",

month = oct,

day = "1",

doi = "https://doi.org/10.1158/1538-7445.AM2014-2989",

language = "English",

volume = "74",

journal = "Cancer research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "19",

}

TY - JOUR

T1 - High-dose, intermittent sunitinib as an alternative treatment strategy

AU - Rovithi, Maria

AU - de Haas, Richard R.

AU - Honeywell, Richard J.

AU - Voortman, Johannes

AU - Griffioen, Arjan W.

AU - Labots, Mariette

AU - Luik, Anne Marije

AU - Peters, Godefridus J.

AU - Broxterman, Henk J.

AU - Verheul, Henk M. W.

PY - 2014/10/1

Y1 - 2014/10/1

U2 - https://doi.org/10.1158/1538-7445.AM2014-2989

DO - https://doi.org/10.1158/1538-7445.AM2014-2989

M3 - Meeting Abstract

SN - 0008-5472

VL - 74

JO - Cancer research

JF - Cancer research

IS - 19

ER -